Latest news with #LYNX
Yahoo
18-05-2025
- Automotive
- Yahoo
2 Orange County deadly LYNX bus crashes in less than 24 hours, troopers say
The Brief In the past 24 hours, the Florida Highway Patrol (FHP) has reported two deadly LYNX bus crashes in the Orange County area. Troopers say the first crash involved a pedestrian attempting to cross State Road 50, and the second occurred when a LYNX bus overturned after a speeding driver lost control of his Tesla. LYNX was not cited for either of the crashes. ORANGE COUNTY, Fla. - In the past 24 hours, the Florida Highway Patrol (FHP) has reported two deadly LYNX bus crashes in the Orange County area. Troopers say the first crash involved a pedestrian attempting to cross State Road 50, and the second occurred when a LYNX bus overturned after a speeding driver lost control of his Tesla. Here's everything we know about the two crashes and LYNX bus safety. The backstory A LYNX bus hit and killed a pedestrian around 9:12 p.m. on Friday, May 16, in the Orange County area. A crash report shows a LYNX bus was traveling westbound on S.R. 50, also known as West Colonial Drive, approaching Charles Street in the outside lane. Meanwhile, a pedestrian was walking north and entered the westbound lanes of S.R. 50. Officials said the pedestrian was not in a marked crosswalk and entered the direct path of the bus. Authorities said the front of the bus struck the pedestrian, and they were transported to the hospital and later pronounced dead. The pedestrian was identified as a 67-year-old woman from Orlando. FHP said the driver and passengers on the bus were not injured. One person was killed, and multiple others were injured, following a Saturday crash in Orange County. Officials said the crash happened around 2:30 p.m. in the area of Wetherbee Road. Troopers say a 2017 Tesla was speeding as it approached the intersection of Isle Wright Drive, and the vehicle then collided with the bus after changing lanes to avoid a slower-moving vehicle. The collision caused the bus to overturn on its side before landing on the sidewalk and roadway. The driver of the Tesla was transported to an area hospital with serious injuries. Troopers said the bus driver sustained minor injuries, while a 75-year-old passenger was transported to a hospital and later pronounced dead. What's next Authorities say both crashes currently remain under investigation. LYNX was not cited for either of the crashes. What they're saying On its website, LYNX says its mission is to "provide safe, secure, reliable and efficient transportation services" to its customers. Dig deeper FOX 35 News has reached out to LYNX officials for more information on safety measures involving the buses and is working to learn how many crashes have taken place involving LYNX buses in the Central Florida area in the last few years. STAY CONNECTED WITH FOX 35 ORLANDO: Download the FOX Local app for breaking news alerts, the latest news headlines Download the FOX 35 Storm Team Weather app for weather alerts & radar Sign up for FOX 35's daily newsletter for the latest morning headlines FOX Local:Stream FOX 35 newscasts, FOX 35 News+, Central Florida Eats on your smart TV The Source This story was written based on information shared by the Florida Highway Patrol (FHP) in two separate crash reports on May 17, 2025.
New York Times
12-02-2025
- Sport
- New York Times
Connections: Sports Edition Coach: Hints, facts about puzzle No. 142
Need help with today's Connections: Sports Edition puzzle? You've come to the right place. Welcome to Connections: Sports Edition Coach — a spot to gather clues and discuss (and share) scores. A quick public service announcement before we continue: The bottom of this article includes one answer in each of the four categories. So if you want to solve the board hint-free, we recommend you play before continuing. Advertisement You can access Wednesday's game here. Game No. 142's difficulty: 3 out of 5 Scroll below for one answer in each of the four categories. . . . . . . . . . . . . . . . . . . . . Yellow: GAMBIT Green: LYNX Blue: SOUVENIR Purple: NORTH STARS The next puzzle will be available at midnight in your time zone. Thanks for playing — and share your scores in the comments! (Illustration: Dan Goldfarb / The Athletic)
Yahoo
29-01-2025
- Business
- Yahoo
Lyndra Therapeutics appoints Adam Sayer new CEO and president
Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO. Sayer, who will also join the company's board of directors, brings experience from his previous role as chief transformation officer at Envision Healthcare. With an understanding of the healthcare ecosystem, Sayer's expertise in strategy, transformation and payer negotiations is expected to be pivotal in progressing the company's programmes, particularly oral weekly risperidone (LYN-005). This long-acting therapeutic is a key focus for the company as it strives to enhance patient experience by offering less frequent dosing. The pivotal safety trial for LYN-005 is scheduled to begin in the first half of 2025. Adam stated: 'I am excited to join Lyndra at this pivotal moment for the company. Lyndra's LYNX platform technology has demonstrated remarkable potential to transform oral medicine delivery and make a meaningful impact on patient outcomes, and I look forward to leading this talented team as we bring the first-ever long-acting oral medicines to market.' Under the stewardship of Jessica Ballinger, outgoing CEO and president, the company completed a pivotal efficacy study for LYN-005. Lyndra Therapeutics board executive chair and co-founder Amy Schulman stated: 'We are grateful for Jess's contributions and overall dedication to our mission. Now, under Adam's leadership and with his focus on business execution, we are poised to achieve our goals and fundamentally change how oral medicines are delivered.' The company recently entered a strategic partnership with Thermo Fisher Scientific, focusing on commercial manufacturing and clinical research on a global scale. Lyndra's LYNX drug delivery platform is tailored to deliver treatments for a week or more in one oral dose. The platform's flexibility and potential have been showcased through clinical proof-of-concept studies across 25 active pharmaceutical ingredients and five therapeutic areas. "Lyndra Therapeutics appoints Adam Sayer new CEO and president" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
